Stryker (SYK) Q4 2025 Earnings
Stryker reported Q4 2025 revenue of $7.2B (+11.4% YoY), beat analyst consensus of $7.1B by $46.4M. Diluted EPS came in at $4.47 (+11.5% YoY), beat the $4.40 consensus by $0.07. Stryker reports across 2 business segments, led by MedSurg and Neurotechnology and Orthopaedics.
Q4 2025 Earnings FAQ
Common questions about Stryker's Q4 2025 earnings report.
Stryker (SYK) reported Q4 2025 earnings on January 29, 2026 after market close.
Stryker reported revenue of $7.2B and diluted EPS of $4.47 for Q4 2025.
Revenue beat the consensus estimate of $7.1B by $46.4M. EPS beat the consensus estimate of $4.40 by $0.07.
Compared to the same quarter a year prior, revenue grew 11.4% from $6.4B a year earlier and diluted EPS grew 11.5% from $4.01.
Stryker reports across 2 business segments, led by MedSurg and Neurotechnology and Orthopaedics. Segment-level financials are available on the company's metrics pages.
You can read the 8-K earnings release (0000310764-26-000006) directly on SEC EDGAR. The filing index links above go to sec.gov.